🇺🇸 FDA
Patent

US 8791136

Substituted pyridine, pyridazine, pyrazine and pyrimidine compounds and methods for using the same

granted A61PA61P1/04A61P1/14

Quick answer

US patent 8791136 (Substituted pyridine, pyridazine, pyrazine and pyrimidine compounds and methods for using the same) held by Rigel Pharmaceuticals, Inc. expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P1/04, A61P1/14, A61P1/16, A61P1/18